ArticleOPEN ACCESS

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies (Clinical Reviews in Allergy & Immunology, (2018), 10.1007/s12016-018-8675-2)

Clinical Reviews in Allergy and Immunology
DOI: 10.1007/s12016-018-8682-3
0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The original version of this article unfortunately contained a mistake. Maddalena Larosa’s given name and surname were inadvertently interchanged.

Cite

CITATION STYLE

APA

Trentin, F., Gatto, M., Zen, M., Larosa, M., Nalotto, L., Saccon, F., … Doria, A. (2018, June 1). Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies (Clinical Reviews in Allergy & Immunology, (2018), 10.1007/s12016-018-8675-2). Clinical Reviews in Allergy and Immunology. Humana Press Inc. https://doi.org/10.1007/s12016-018-8682-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free